Bristol-Myers Squibb Proceeds from Bridge Loan increased by 6320.0% to $321.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 12.8%, from $368.00M to $321.00M.
rtx_proceeds_from_bridge_loan| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $48.50M | $48.50M | $48.50M | $48.50M | -$353.00M | $83.00M | $326.00M | $95.00M | $368.00M | $58.00M | $5.00M | $321.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -827.8% | +123.5% | +292.8% | -70.9% | +287.4% | -84.2% | -91.4% | >999% |
| YoY Change | — | — | — | — | -827.8% | — | — | — | +343.4% | -82.2% | -94.7% | -12.8% |